DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+13.89%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$372M
AUM Growth
+$372M
Cap. Flow
-$24.6M
Cap. Flow %
-6.63%
Top 10 Hldgs %
47.82%
Holding
98
New
8
Increased
10
Reduced
34
Closed
10

Top Buys

1
RVMD icon
Revolution Medicines
RVMD
$3.55M
2
MDWD icon
MediWound
MDWD
$1.99M
3
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.71M
4
LRMR icon
Larimar Therapeutics
LRMR
$1.68M
5
KURA icon
Kura Oncology
KURA
$1.21M

Top Sells

1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$7.46M
2
NTUS
Natus Medical Inc
NTUS
$4.71M
3
XBI icon
SPDR S&P Biotech ETF
XBI
$3.73M
4
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$3.65M
5
XENE icon
Xenon Pharmaceuticals
XENE
$2.29M

Sector Composition

1 Healthcare 81.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VERO icon
76
Venus Concept
VERO
$4.07M
$426K 0.11%
5,868
– –
MASI icon
77
Masimo
MASI
$7.43B
$423K 0.11%
3,000
– –
ADAP
78
Adaptimmune Therapeutics
ADAP
$13.9M
$377K 0.1%
351,064
– –
INGN icon
79
Inogen
INGN
$213M
$364K 0.1%
15,000
– –
MGNX icon
80
MacroGenics
MGNX
$121M
$346K 0.09%
100,000
-92,000
-48% -$318K
BMEA icon
81
Biomea Fusion
BMEA
$114M
$339K 0.09%
34,625
-102,310
-75% -$1M
SPRO icon
82
Spero Therapeutics
SPRO
$117M
$250K 0.07%
+125,000
New +$250K
LCTX icon
83
Lineage Cell Therapeutics
LCTX
$281M
$158K 0.04%
140,000
– –
REUN
84
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
$138K 0.04%
96,585
-284,243
-75% -$406K
CGEN icon
85
Compugen
CGEN
$133M
$135K 0.04%
205,202
– –
PHAS
86
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$57K 0.02%
321,856
-56,755
-15% -$10.1K
NTUS
87
DELISTED
Natus Medical Inc
NTUS
– –
-143,600
Closed -$4.71M
RDUS
88
DELISTED
Radius Health, Inc.
RDUS
– –
-91,935
Closed -$953K
TPTX
89
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-48,452
Closed -$3.65M
ASLN
90
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
– –
-8,593
Closed -$170K
WVE icon
91
Wave Life Sciences
WVE
$1.27B
– –
-372,361
Closed -$1.21M
RIGL icon
92
Rigel Pharmaceuticals
RIGL
$710M
– –
-39,007
Closed -$441K
MDGL icon
93
Madrigal Pharmaceuticals
MDGL
$9.7B
– –
-3,100
Closed -$222K
LVTX icon
94
LAVA Therapeutics
LVTX
$41.3M
– –
-128,335
Closed -$379K
CNTB
95
Connect Biopharma
CNTB
$111M
– –
-250,000
Closed -$218K
ANNX icon
96
Annexon
ANNX
$225M
– –
-40,796
Closed -$154K
1 2 3
4